Ginkgo Bioworks Statistics
NYSE: DNAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
11.47-0.94 (-7.57%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 11.38 -0.78%
Ginkgo Bioworks by the numbers
Ginkgo Bioworks has a market capitalization of $772.4 million based on 55.38M shares outstanding. With trailing EPS of $-5.06, Ginkgo Bioworks is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 37.7% above its 50-day average and 36.9% above its 200-day average.
Average daily trading volume is 1.68M shares, or about $19.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
DNA valuation vs. peer median
| Metric | DNA | Peer median | Difference |
|---|---|---|---|
| Market cap | $772.39M | $782.84M | -1% |
| Avg. volume | 1.68M | 1.17M | +44% |
Peer median across 8 companies: SANA, CADL, SLBT, ATTO, SLDB, GLUE, ODTX, PRME.
Valuation
- Market cap
- $772.39M
- EPS (TTM)
- $-5.06
- Shares outstanding
- 55.38M
Price and trading
- Previous close
- 12.41
- Open
- 11.81
- Day range
- 10.82 – 11.95
- 52-week range
- 5.37 – 18.22
- 52-week change
- -22.60%
- Beta
- —
- Volume
- 6.45M
- Average volume
- 1.68M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 772.39M
- Forward Pe
- -3.96
- Eps
- -5.06
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 18.22
- Week52 Low
- 5.37
- Avg Volume
- 1.68M
- Shares Outstanding
- 55.38M
- Ma50
- 8.33
- Ma200
- 8.38
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -37.05%
- Pct From52w Low
- 113.59%